

by admin | Feb 10, 2021 | Pharmaceutical Litigation, Singulair
In March 2020, FDA added stronger warnings about the potential psychiatric side effects of Singulair, an asthma and allergy drug. Studies have linked the medication to reports of depression, suicidal behavior, and other mental health risks. About Singulair Singulair...
Recent Comments